Low-affinity neurotrophin receptor p75 promotes the transduction of targeted lentiviral vectors to cholinergic neurons of rat basal forebrain.
Neurotherapeutics 13, 859-870 (2016)
Basal forebrain cholinergic neurons (BFCNs) are one of the most affected neuronal types in Alzheimer's disease (AD), with their extensive loss documented at late stages of the pathology. While discriminatory provision of neuroprotective agents and trophic factors to these cells is thought to be of substantial therapeutic potential, the intricate topography and structure of the forebrain cholinergic system imposes a major challenge. To overcome this, we took advantage of the physiological enrichment of BFCNs with a low-affinity p75 neurotrophin receptor (p75(NTR)) for their targeting by lentiviral vectors within the intact brain of adult rat. Herein, a method is described that affords selective and effective transduction of BFCNs with a green fluorescence protein (GFP) reporter, which combines streptavidin-biotin technology with anti-p75(NTR) antibody-coated lentiviral vectors. Specific GFP expression in cholinergic neurons was attained in the medial septum and nuclei of the diagonal band Broca after a single intraventricular administration of such targeted vectors. Bioelectrical activity of GFP-labeled neurons was proven to be unchanged. Thus, proof of principle is obtained for the utility of the low-affinity p75(NTR) for targeted transduction of vectors to BFCNs in vivo.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Alzheimer’s Disease ; Basal Forebrain Cholinergic Neurons ; Gene Therapy ; Neuroprotection ; Streptavidin–biotin ; P75 Neurotrophin Receptor; Nerve Growth-factor; Factor Gene-therapy; Alzheimers-disease; In-vivo; Neurodegenerative Diseases; Retrograde Transport; Septohippocampal Gaba; Discharge Properties; Nucleus Basalis; Selective Loss
Keywords plus
Language
english
Publication Year
2016
Prepublished in Year
HGF-reported in Year
2016
ISSN (print) / ISBN
1933-7213
e-ISSN
1878-7479
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 13,
Issue: 4,
Pages: 859-870
Article Number: ,
Supplement: ,
Series
Publisher
Springer
Publishing Place
New York, NY
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30205 - Bioengineering and Digital Health
30202 - Environmental Health
Research field(s)
Enabling and Novel Technologies
Radiation Sciences
PSP Element(s)
G-505500-001
G-500200-001
Grants
Copyright
Erfassungsdatum
2016-06-02